Locations:
Search
Understudied Src Family Kinase may serve as a potential therapeutic target
Sarcopenia and sarcopenic obesity appear to increase risk of early chemotherapy termination
Study associates human CD38-targeting antibody with fewer complications
Retired-protein strategy represents new approach to immunization
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Current trials study novel therapies for rhabdomyosarcoma and clear cell sarcoma
Should institutions adopt “time to treatment” as a new quality metric?
A multidisciplinary team of Cleveland Clinic scientists looks to evolution for answers
Early recognition is key to effective management
May not translate to better outcomes
Underfunding could impact clinical trial development
Advertisement
Advertisement